SABR in oligometastatic breast cancer: Current status and future directions
Oligometastatic breast cancer (OMBC) is a heterogeneous disease with intrinsic biological diversity. It is increasingly accepted in clinical practice that patients with OMBC could be treated with the expectation of long-term disease remission. Local ablative treatments, such as radiotherapy or surge...
Guardado en:
Autores principales: | Rachel Stewart, Michelle White, Jennifer Tan, Shankar Siva, Lama Karroum, Steven David |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fef5ad287b3d47d186dc6b1a21098ab2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: David L. Billing, et al.
Publicado: (2021) -
Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard PJ, et al.
Publicado: (2016) -
Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
por: Yilin Cao, et al.
Publicado: (2021) -
Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Kristin A. Plichta, et al.
Publicado: (2021) -
Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
por: Danyang Zhou, et al.
Publicado: (2021)